,Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
0,prerank,KEGG_2021_Human__Ribosome,-0.7846952418832418,-2.8654347188050395,0.0,0.0,0.0,60/101,12.95%,RPL22L1;RPS6;RPL12;RPL31;RPL35;RPL3;RPS26;RPL35A;RPL4;RPS11;RPL10A;RPS29;RPS8;RPS19;RPL10;RPS15;MRPS15;RPLP1;RPL26;RPL23A;RPS21;RPS4Y2;RPL23;RPS20;RPLP2;RPL7;RPL34;RPS17;RPS16;RPS18;RPS23;RPL18;RPS3A;RPL8;RPL18A;RPL13;RPLP0;RPL6;RPS27A;RPS7;RPL15;RPL28;RPL21;RPS25;RPS28;RPS5;RPL29;RPL11;RPL9;RPL27A;RPS15A;RPS24;MRPL34;RPL36;RPS3;RPL14;RPL30;MRPS21;RPL32;MRPL18
1,prerank,MSigDB_Hallmark_2020__Interferon Alpha Response,0.8452682309648718,2.252963509597012,0.0,0.0,0.0,54/79,7.37%,ISG15;IFI27;BST2;IRF7;UBE2L6;LGALS3BP;RTP4;IFI44;CSF1;OASL;PSMB9;PSMB8;TRAFD1;IFIT2;HERC6;GBP2;MX1;DDX60;DHX58;TMEM140;NMI;OGFR;PSME2;SAMD9L;SP110;ISG20;IRF9;IFIT3;TAP1;UBA7;RSAD2;PARP9;GBP4;CCRL2;STAT2;TRIM21;WARS1;PSME1;CNP;IFIH1;SAMD9;PARP14;EIF2AK2;PARP12;MOV10;TRIM5;ADAR;HELZ2;CMTR1;IL4R;CMPK2;TRIM26;EPSTI1;CXCL10
2,prerank,MSigDB_Hallmark_2020__Interferon Gamma Response,0.7755846811723317,2.148056744470335,0.0,0.0,0.0,80/140,12.64%,ISG15;IFI27;BST2;IRF7;UBE2L6;LGALS3BP;RTP4;IFI44;OASL;PSMB9;XAF1;PSMB8;TRAFD1;IFIT2;HERC6;MX1;DDX60;DHX58;NMI;OGFR;PSME2;SAMD9L;SP110;ISG20;CDKN1A;IRF9;IFIT3;TAP1;DDX58;GBP6;NLRC5;UPP1;RSAD2;CD274;GBP4;STAT2;ZBP1;OAS3;RNF213;TRIM21;WARS1;PSME1;PTPN6;ZNFX1;IFIH1;NAMPT;PARP14;FAS;IFNAR2;EIF2AK2;PARP12;ADAR;HELZ2;CMTR1;SOCS1;IL4R;GCH1;SERPING1;SOD2;CMPK2;TRIM26;EPSTI1;CXCL10;PML;TNFSF10;CASP3;STAT1;ICAM1;B2M;CCL2;BATF2;VAMP8;CASP1;FPR1;TNFAIP6;TNFAIP2;IRF1;IL15RA;IDO1;PELI1
3,prerank,KEGG_2021_Human__Amphetamine addiction,-0.7075421355560705,-1.936821945825691,0.0,0.025912838633686687,0.021,7/19,11.22%,PRKACB;FOSB;GNAS;PPP3CB;CALM3;CALM2;FOS
4,prerank,MSigDB_Hallmark_2020__Inflammatory Response,0.6827460607541085,1.8505315575915349,0.0,0.000527176876931467,0.002,54/97,20.09%,BST2;IRF7;RTP4;CSF1;CD14;INHBA;NMI;CLEC5A;CDKN1A;P2RY2;CCRL2;PLAUR;RHOG;NAMPT;RGS1;EIF2AK2;PTPRE;IL4R;FFAR2;GCH1;TIMP1;CXCL10;PTAFR;TNFSF10;ICAM1;TLR2;CCL2;HBEGF;SLC28A2;FPR1;TNFAIP6;MXD1;CSF3R;SLC31A2;IRF1;IL15RA;RELA;RIPK2;ABCA1;NOD2;PIK3R5;MSR1;SEMA4D;SLAMF1;ADRM1;LY6E;NFKBIA;CXCL11;IFNGR2;C3AR1;OSM;PTGER2;LCP2;EMP3
5,prerank,KEGG_2021_Human__Melanogenesis,-0.6305779061390471,-1.8435101687591977,0.0,0.04161758932076953,0.049,7/22,8.56%,PRKACB;TCF7;GNAS;PLCB2;CALM3;ADCY7;CALM2
6,prerank,KEGG_2021_Human__Aldosterone synthesis and secretion,-0.6485688035585884,-1.818716484626503,0.0,0.04240282685512367,0.062,8/20,8.56%,PRKACB;LDLR;GNAS;NR4A2;PLCB2;CALM3;ADCY7;CALM2
7,prerank,MSigDB_Hallmark_2020__IL-6/JAK/STAT3 Signaling,0.7182918766680392,1.7870689884337017,0.0,0.0025699872750409017,0.013,27/46,14.95%,CSF1;CD14;IL1R2;IRF9;STAT2;CSF2RA;HMOX1;FAS;BAK1;CXCL3;IFNGR1;SOCS1;TNFRSF1A;IL4R;IL10RB;CXCL10;STAT1;TLR2;LTBR;CSF3R;IRF1;IL15RA;PIK3R5;IL13RA1;SOCS3;CCR1;MYD88
8,prerank,KEGG_2021_Human__Influenza A,0.6591312189808752,1.7773280230704513,0.0,0.0022141428831121616,0.014,36/89,14.95%,IRF7;MX1;IRF9;DDX58;RSAD2;STAT2;OAS3;ACTG1;IFIH1;CCND3;FAS;IFNAR2;EIF2AK2;ADAR;BAK1;IFNGR1;TNFRSF1A;CXCL10;PML;DNAJC3;TNFSF10;CASP3;STAT1;ICAM1;BAX;CCL2;CASP1;TMPRSS4;RAB11A;NFKBIB;RELA;KPNA5;TLR4;BID;SOCS3;MYD88
9,prerank,KEGG_2021_Human__Oocyte meiosis,-0.5236168872212049,-1.7604863701068245,0.0,0.0636042402826855,0.113,12/41,8.56%,PRKACB;ANAPC13;PPP3CB;SLK;SMC3;RPS6KA3;CALM3;ADCY7;ANAPC4;CPEB2;ANAPC5;CALM2
10,prerank,KEGG_2021_Human__Progesterone-mediated oocyte maturation,-0.5563853826741493,-1.7577019678717833,0.011976047904191617,0.05418138987043581,0.116,10/31,10.35%,PRKACB;CDC25B;ANAPC13;RPS6KA3;PIK3CD;ADCY7;ANAPC4;CPEB2;ANAPC5;AKT1
11,prerank,MSigDB_Hallmark_2020__Myc Targets V1,-0.43555990846325177,-1.7122712996002314,0.0,0.06562342251388188,0.159,48/122,18.28%,RPS6;EEF1B2;SRSF3;RPL34;SRPK1;RPL18;GSPT1;NAP1L1;RPLP0;RPL6;PABPC1;RACK1;NPM1;EPRS1;HSPD1;SNRPA1;RPS5;PA2G4;LSM2;IMPDH2;G3BP1;SSB;VBP1;SMARCC1;DDX21;SRSF2;SNRPD3;HSPE1;ERH;RPS3;RPL14;NOP56;NCBP2;VDAC3;DHX15;RPL22;MRPL23;XPO1;SRSF7;SERBP1;USP1;RPS2;NDUFAB1;RANBP1;SRSF1;C1QBP;POLE3;CCT4
12,prerank,KEGG_2021_Human__Cytokine-cytokine receptor interaction,0.6633561447310692,1.706219948941419,0.0,0.01383839301945101,0.081,28/60,15.30%,CSF1;IL1R2;INHBA;CXCL16;CSF2RA;NODAL;FAS;IFNAR2;IL1RN;CXCL3;CCR9;IFNGR1;CCL3L3;CCL8;TNFRSF1A;IL4R;IL10RB;CXCL10;TNFSF10;CCL4L2;CCL2;LTBR;CSF3R;IL15RA;CCR5;IL13RA1;CCR1;CXCR2
13,prerank,KEGG_2021_Human__Coronavirus disease,-0.4401870697333184,-1.7016222291149734,0.0,0.06183745583038869,0.17,53/133,9.45%,RPL22L1;RPS6;RPL12;RPL31;RPL35;RPL3;RPS26;RPL35A;RPL4;RPS11;RPL10A;RPS29;RPS8;RPS19;RPL10;RPS15;RPLP1;RPL26;RPL23A;RPS21;RPS4Y2;RPL23;RPS20;RPLP2;RPL7;RPL34;RPS17;RPS16;RPS18;RPS23;RPL18;RPS3A;RPL8;RPL18A;RPL13;PIK3CD;RPLP0;RPL6;RPS27A;RPS7;RPL15;RPL28;RPL21;RPS25;RPS28;RPS5;RPL29;RPL11;RPL9;RPL27A;RPS15A;RPS24;C3
14,prerank,KEGG_2021_Human__NOD-like receptor signaling pathway,0.6401219851771077,1.6991574827392135,0.001072961373390558,0.01423377567714961,0.096,37/85,19.47%,IRF7;IFI16;GBP2;GSDMD;IRF9;GBP7;GBP4;STAT2;OAS3;NAMPT;MAPK13;IFNAR2;GABARAP;CXCL3;CTSB;BIRC3;STAT1;CCL2;CASP1;GBP5;NFKBIB;RELA;TRAF5;VDAC2;TLR4;RIPK2;NOD2;RBCK1;MYD88;RIPK1;NFKBIA;TRAF2;RHOA;STING1;GABARAPL1;CAMP;CYBA
15,prerank,KEGG_2021_Human__Estrogen signaling pathway,-0.496915443975309,-1.6922572768216542,0.007692307692307693,0.059939798455699515,0.187,13/44,11.22%,PRKACB;NCOA3;GNAS;PIK3CD;PLCB2;CALM3;ADCY7;HSPA2;HSPA8;CALM2;AKT1;FKBP4;FOS
16,prerank,KEGG_2021_Human__Hepatitis C,0.6243113881493327,1.6734660303518893,0.0,0.020757589529176515,0.157,28/80,18.09%,IRF7;MX1;CDKN1A;IRF9;DDX58;RSAD2;STAT2;OAS3;FAS;IFNAR2;EIF2AK2;BAK1;TNFRSF1A;CXCL10;CASP3;STAT1;BAX;CLDN1;RELA;CFLAR;CLDN5;BID;SOCS3;RIPK1;NFKBIA;TRAF2;YWHAH;CYCS
17,prerank,KEGG_2021_Human__RIG-I-like receptor signaling pathway,0.6930122530723687,1.6667136931285305,0.0035294117647058825,0.02091134945161486,0.177,15/35,18.47%,ISG15;IRF7;DHX58;DDX58;IFIH1;MAPK13;CXCL10;AZI2;RNF125;NFKBIB;RELA;RIPK1;NFKBIA;TRAF2;STING1
18,prerank,KEGG_2021_Human__Calcium signaling pathway,-0.536450336301762,-1.6585665997339076,0.005649717514124294,0.06760895170789163,0.229,14/30,13.68%,PRKACB;SLC25A4;GNAS;PPP3CB;SLC25A5;RET;PLCB2;CALM3;ADCY7;CALM2;ADRB2;ATP2A3;VDAC3;VEGFA
19,prerank,KEGG_2021_Human__Cytosolic DNA-sensing pathway,0.7098344073967837,1.6481821607407903,0.0036719706242350062,0.02609525540810762,0.232,14/28,18.47%,IRF7;DDX58;ZBP1;ADAR;CGAS;CXCL10;CCL4L2;CASP1;NFKBIB;RELA;RIPK1;POLR3C;NFKBIA;STING1
20,prerank,KEGG_2021_Human__Salivary secretion,-0.6186700193788112,-1.6352926316703338,0.03474903474903475,0.07281293500374772,0.269,8/15,11.45%,PRKACB;GNAS;PLCB2;CALM3;ADCY7;CALM2;ADRB2;LYZ
21,prerank,KEGG_2021_Human__JAK-STAT signaling pathway,0.6483940112645127,1.6257773523947885,0.003416856492027335,0.03429045958586042,0.311,21/47,19.20%,CDKN1A;IRF9;STAT2;CSF2RA;PTPN6;CISH;CCND3;IFNAR2;IFNGR1;SOCS1;IL4R;IL10RB;STAT1;CSF3R;IL15RA;IL13RA1;SOCS3;MCL1;IFNGR2;SOCS2;OSM
22,prerank,KEGG_2021_Human__Epithelial cell signaling in Helicobacter pylori infection,0.6781639704860464,1.6252943864925429,0.002380952380952381,0.03196009816397019,0.313,20/32,25.88%,ATP6V1F;ATP6V1G1;MAPK13;CXCL3;TCIRG1;CASP3;ATP6V1B2;HBEGF;RELA;ATP6V0E1;CXCR2;ATP6V0B;ATP6V1C1;NFKBIA;CDC42;LYN;ATP6V0D1;ATP6V1A;CCL5;ADAM17
23,prerank,MSigDB_Hallmark_2020__Apoptosis,0.6101273151502138,1.615815118859661,0.0,0.034854501978661225,0.358,30/75,13.95%,CD14;ISG20;CDKN1A;TAP1;SQSTM1;TSPO;LGALS3;HMOX1;FAS;DDIT3;IFNGR1;GCH1;SOD2;TIMP1;GSN;DNAJC3;BIRC3;TNFSF10;CASP3;ATF3;BAX;DAP;CASP1;IRF1;RELA;BNIP3L;CFLAR;VDAC2;PPT1;BID
24,prerank,KEGG_2021_Human__Herpes simplex virus 1 infection,0.5915912816661828,1.6071677175333023,0.0,0.03744838600773886,0.395,36/96,18.47%,BST2;IRF7;IRF9;TAP1;DDX58;STAT2;TAP2;OAS3;IFIH1;FAS;IFNAR2;EIF2AK2;BAK1;CGAS;IFNGR1;TNFRSF1A;PML;BIRC3;CASP3;STAT1;B2M;BAX;TLR2;CCL2;RHEB;RELA;SYK;TRAF5;BID;SOCS3;MYD88;NFKBIA;TRAF2;CYCS;IFNGR2;STING1
25,prerank,KEGG_2021_Human__Regulation of lipolysis in adipocytes,-0.6093528815943837,-1.5991391316763652,0.02834008097165992,0.09069493521790342,0.333,6/16,10.35%,PRKACB;GNAS;PIK3CD;ADCY7;ADRB2;AKT1
26,prerank,KEGG_2021_Human__Proteasome,0.6532531561953191,1.5966686332993096,0.0035335689045936395,0.04175240865297218,0.448,9/40,10.10%,PSMB9;PSMB8;PSME2;PSMA5;PSME1;POMP;PSMD8;PSMA1;PSMB3
27,prerank,MSigDB_Hallmark_2020__TNF-alpha Signaling via NF-kB,0.583517048523388,1.5961411339784797,0.0,0.03963711143428467,0.451,70/122,25.07%,CSF1;IFIT2;INHBA;CDKN1A;TAP1;DDX58;CD80;SQSTM1;CCRL2;PLAUR;IFIH1;SLC2A6;NAMPT;EGR2;ETS2;CXCL3;CEBPB;PTPRE;PNRC1;GCH1;SOD2;NFIL3;CXCL10;BIRC3;ATF3;ICAM1;CEBPD;TLR2;CCL2;HBEGF;SDC4;TNFAIP6;TNFAIP2;BCL2A1;MXD1;LITAF;IRF1;IL15RA;RELA;CFLAR;PER1;RIPK2;ABCA1;SOCS3;BCL3;EHD1;MCL1;NFKBIA;CXCL11;TGIF1;IFNGR2;RELB;MAP2K3;EIF1;IER3;TRIB1;KLF6;PLEK;MAFF;CLCF1;ZC3H12A;TNFAIP3;CD69;CD44;PDE4B;MAP3K8;TNFAIP8;ATP2B1;PTGS2;CCL5
28,prerank,KEGG_2021_Human__Toll-like receptor signaling pathway,0.6220420135604873,1.5906309511608003,0.003386004514672686,0.04014296865810494,0.471,19/54,17.34%,IRF7;CD14;CD80;MAPK13;IFNAR2;LBP;SPP1;CCL3L3;CXCL10;CCL4L2;STAT1;TLR2;TIRAP;RELA;TLR4;MYD88;RIPK1;NFKBIA;CXCL11
29,prerank,KEGG_2021_Human__Citrate cycle (TCA cycle),-0.5836437041801245,-1.5893408661593948,0.033816425120772944,0.0906043308870164,0.356,5/19,11.93%,IDH2;PDHA1;ACLY;MDH1;FH
30,prerank,KEGG_2021_Human__Necroptosis,0.6076900621833251,1.5858361928603182,0.0032822757111597373,0.040416893898079134,0.49,29/62,18.16%,IRF9;FTH1;SQSTM1;STAT2;ZBP1;FAS;IFNAR2;EIF2AK2;IFNGR1;TNFRSF1A;FTL;BIRC3;TNFSF10;STAT1;BAX;CASP1;TRAF5;CHMP5;CFLAR;VDAC2;TLR4;CHMP2A;BID;SMPD1;RBCK1;RIPK1;RNF103-CHMP3;TRAF2;IFNGR2
31,prerank,KEGG_2021_Human__NF-kappa B signaling pathway,0.6196218404749145,1.571861363157507,0.0011337868480725624,0.04732106124245353,0.553,24/52,18.55%,CD14;DDX58;LBP;CXCL3;CSNK2B;TNFRSF1A;BIRC3;CCL4L2;ICAM1;TIRAP;UBE2I;LTBR;BCL2A1;RELA;SYK;TRAF5;CFLAR;TLR4;MYD88;BTK;RIPK1;NFKBIA;TRAF2;RELB
32,prerank,MSigDB_Hallmark_2020__PI3K/AKT/mTOR  Signaling,0.6119068196640896,1.544573372126587,0.01107419712070875,0.06551490638065806,0.674,23/52,20.34%,CDKN1A;CFL1;SQSTM1;STAT2;DDIT3;MKNK1;SLA;CSNK2B;ARHGDIA;TNFRSF1A;ARPC3;SLC2A1;TRIB3;DAPP1;RIT1;NFKBIB;RPS6KA1;MYD88;RIPK1;TRAF2;PFN1;MAP2K3;PPP1CA
33,prerank,MSigDB_Hallmark_2020__Cholesterol Homeostasis,0.6521100131184476,1.5434431654428353,0.010935601458080195,0.06360012465266056,0.678,11/31,11.37%,FABP5;S100A11;CXCL16;ACTG1;PLAUR;LGALS3;PNRC1;NFIL3;ATF3;TRIB3;ETHE1
34,prerank,KEGG_2021_Human__Measles,0.5701583428432344,1.5192569916606264,0.003257328990228013,0.08410867445588405,0.779,25/77,15.74%,IRF7;MX1;IRF9;DDX58;STAT2;OAS3;IFIH1;CCND3;FAS;IFNAR2;EIF2AK2;FCGR2B;ADAR;BAK1;CSNK2B;CASP3;STAT1;BAX;TLR2;NFKBIB;RELA;TLR4;BID;MYD88;SLAMF1
35,prerank,KEGG_2021_Human__Renin secretion,-0.5577189050134844,-1.5173008994199735,0.01680672268907563,0.13932357395254924,0.505,7/18,9.72%,PRKACB;GNAS;PPP3CB;PLCB2;CALM3;CALM2;ADRB2
36,prerank,KEGG_2021_Human__Rheumatoid arthritis,0.6229960328273806,1.5050633790610144,0.016412661195779603,0.0951668866530196,0.823,15/35,16.84%,CSF1;ATP6V1F;CD80;ATP6V1G1;CXCL3;CCL3L3;TCIRG1;ICAM1;ATP6V1B2;TLR2;CCL2;TLR4;ATP6V0E1;ATP6V0B;ATP6V1C1
37,prerank,KEGG_2021_Human__Gap junction,-0.5043648362387854,-1.502898048479283,0.034653465346534656,0.14322732626619553,0.525,6/24,7.89%,PRKACB;TUBB;GNAS;PLCB2;ADCY7;TUBB3
38,prerank,KEGG_2021_Human__TNF signaling pathway,0.5798401046758896,1.4992822133065438,0.007717750826901874,0.09904335575349937,0.848,22/57,18.97%,CSF1;FAS;MAPK13;CXCL3;CEBPB;TNFRSF1A;CXCL10;BIRC3;CASP3;ICAM1;CCL2;IRF1;RELA;TRAF5;CFLAR;NOD2;SOCS3;BCL3;RIPK1;NFKBIA;TRAF2;MAP2K3
39,prerank,MSigDB_Hallmark_2020__Hypoxia,0.5688544939690229,1.4991408328800855,0.00974025974025974,0.09527140519905472,0.849,24/73,15.68%,ISG20;CDKN1A;PLAC8;TPI1;PLAUR;PLIN2;LDHA;HMOX1;DDIT3;PNRC1;NFIL3;ALDOA;SAP30;ATF3;PFKL;LDHC;PGK1;SLC2A1;SDC4;LALBA;BNIP3L;TES;AKAP12;TPD52
40,prerank,KEGG_2021_Human__Long-term potentiation,-0.5194197511028606,-1.4922711827963544,0.05102040816326531,0.14163722025912837,0.542,6/21,8.56%,PRKACB;PPP3CB;RPS6KA3;PLCB2;CALM3;CALM2
41,prerank,MSigDB_Hallmark_2020__Allograft Rejection,0.5504806517601244,1.48828954802758,0.005336179295624333,0.10425936543006166,0.875,38/93,15.68%,IRF7;CSF1;GBP2;INHBA;TAP1;CD80;TAP2;C2;WARS1;PTPN6;CCND3;FAS;IFNAR2;SRGN;FCGR2B;IFNGR1;SOCS1;IL4R;TIMP1;DEGS1;NCF4;STAT1;ICAM1;B2M;TLR2;CCL2;SPI1;DYRK3;HCLS1;CCR5;RIPK2;FGR;BCL3;CCR1;CD47;AARS1;CTSS;TPD52
42,prerank,KEGG_2021_Human__Dilated cardiomyopathy,-0.5889666429028914,-1.4862969163584696,0.08560311284046693,0.13926418623986697,0.56,7/15,7.56%,ITGA4;PRKACB;LMNA;GNAS;ITGB7;ITGB1;ADCY7
43,prerank,KEGG_2021_Human__Osteoclast differentiation,0.5744891092489045,1.4838861668140142,0.0077777777777777776,0.10607970268032076,0.882,25/60,19.99%,CSF1;IRF9;SQSTM1;STAT2;NCF2;MAPK13;IFNAR2;FCGR2B;IFNGR1;SOCS1;TNFRSF1A;NCF4;STAT1;SPI1;RELA;SYK;SOCS3;BTK;NFKBIA;TRAF2;IFNGR2;TYROBP;RELB;CYBA;LCP2
44,prerank,KEGG_2021_Human__Synaptic vesicle cycle,0.6829014496633099,1.4742769845864947,0.03413400758533502,0.11372899732516165,0.912,9/19,16.84%,ATP6V1F;CLTA;ATP6V1G1;TCIRG1;ATP6V1B2;ATP6V0E1;SLC6A9;ATP6V0B;ATP6V1C1
45,prerank,KEGG_2021_Human__Viral protein interaction with cytokine and cytokine receptor,0.637635173251852,1.4722378478324234,0.022085889570552148,0.11267042355935285,0.918,16/27,17.34%,CSF1;CXCL3;CCR9;CCL3L3;CCL8;TNFRSF1A;IL10RB;CXCL10;TNFSF10;CCL4L2;CCL2;LTBR;CCR5;CCR1;CXCR2;CXCL11
46,prerank,KEGG_2021_Human__Hepatitis B,0.5447559095677454,1.4579270455239197,0.00972972972972973,0.12868387565897108,0.945,20/77,18.97%,IRF7;CDKN1A;DDX58;STAT2;IFIH1;EGR2;FAS;MAPK13;CASP3;STAT1;BAX;TLR2;TIRAP;RELA;TLR4;BID;MYD88;NFKBIA;CYCS;MAP2K3
47,prerank,KEGG_2021_Human__Glycolysis / Gluconeogenesis,0.6408149268512338,1.4550683449793154,0.03622250970245795,0.12894576352686607,0.949,9/24,9.74%,TPI1;LDHA;PKM;ADPGK;ALDOA;PFKL;HK3;LDHC;PGK1
48,prerank,KEGG_2021_Human__Kaposi sarcoma-associated herpesvirus infection,0.5373208137164922,1.4539580100854814,0.015873015873015872,0.12652245046355207,0.952,34/97,18.93%,IRF7;CDKN1A;IRF9;UBB;STAT2;FAS;MAPK13;IFNAR2;EIF2AK2;GABARAP;BAK1;CXCL3;IFNGR1;TNFRSF1A;CD200R1;GNB2;CASP3;STAT1;ICAM1;BAX;RELA;SYK;CCR5;BID;ATG3;PIK3R5;CCR1;GNB1;NFKBIA;UBC;TRAF2;CYCS;MAPKAPK2;GABARAPL1
49,prerank,KEGG_2021_Human__Adipocytokine signaling pathway,0.620996811603552,1.4520333657319064,0.023114355231143552,0.12534828378311383,0.955,11/29,17.66%,PRKAB1;TNFRSF1A;CPT1A;SLC2A1;ADIPOR2;NFKBIB;RELA;SOCS3;NFKBIA;ACSL5;TRAF2
50,prerank,KEGG_2021_Human__Epstein-Barr virus infection,0.5249760444388718,1.4424935304763788,0.005165289256198347,0.1358488296245602,0.965,39/113,19.34%,ISG15;IRF7;CDKN1A;IRF9;TAP1;DDX58;STAT2;TAP2;OAS3;CCND3;FAS;MAPK13;IFNAR2;EIF2AK2;BAK1;SAP30;CXCL10;PSMD8;CASP3;STAT1;ICAM1;B2M;BAX;TLR2;NFKBIB;RELA;SYK;TRAF5;BID;MYD88;BTK;ADRM1;RIPK1;NFKBIA;TRAF2;CYCS;RELB;MAP2K3;SNW1
51,prerank,KEGG_2021_Human__Glutamatergic synapse,-0.4962455142436385,-1.430624633380523,0.03225806451612903,0.18675566025389345,0.662,6/23,7.56%,PRKACB;GNAS;PPP3CB;GLUL;PLCB2;ADCY7
52,prerank,KEGG_2021_Human__Phagosome,0.5351708516841699,1.4294872080440124,0.017679558011049725,0.1520302802087932,0.976,24/71,16.84%,CD14;TAP1;ATP6V1F;TAP2;ACTG1;FCAR;CLEC7A;ATP6V1G1;NCF2;FCGR2B;TUBA4A;TCIRG1;NCF4;ATP6V1B2;TLR2;TLR4;ATP6V0E1;LAMP2;RAB7A;MSR1;RAB5A;CTSS;ATP6V0B;ATP6V1C1
53,prerank,KEGG_2021_Human__Pertussis,0.5735897385377088,1.4125741911079093,0.03002309468822171,0.1774609161970551,0.991,14/42,14.95%,CD14;CFL1;C2;MAPK13;C1QB;SERPING1;C1QA;CASP3;TIRAP;CASP1;IRF1;RELA;TLR4;MYD88
54,prerank,KEGG_2021_Human__Phosphatidylinositol signaling system,-0.4221752992422483,-1.411862471022535,0.013986013986013986,0.20135143512491477,0.699,9/36,10.47%,MTMR1;PIK3CD;INPP4A;PLCB2;CALM3;MTMR6;CALM2;IMPA1;IP6K2
55,prerank,MSigDB_Hallmark_2020__UV Response Up,0.5277273731615075,1.4115132292290762,0.021528525296017224,0.17486599488053772,0.992,26/75,17.09%,TAP1;ATP6V1F;SQSTM1;CNP;CCND3;HMOX1;TMBIM6;BAK1;TUBA4A;GCH1;SOD2;ALDOA;HYAL2;CASP3;GRPEL1;ATF3;ICAM1;GRINA;CDC34;IRF1;TST;PPT1;BID;EIF5;ATP6V1C1;NFKBIA
56,prerank,KEGG_2021_Human__Ferroptosis,0.6306960423464375,1.4084194909476606,0.08194622279129321,0.175924473062314,0.994,12/22,27.21%,GCLM;FTH1;HMOX1;FTL;SLC3A2;VDAC2;PCBP1;ACSL5;GCLC;SLC7A11;LPCAT3;MAP1LC3A
57,prerank,KEGG_2021_Human__Vascular smooth muscle contraction,-0.45741119991768087,-1.407490365782337,0.05952380952380952,0.19646643109540637,0.711,8/28,9.70%,PRKACB;PLA2G2D;GNAS;PLCB2;CALM3;ADCY7;CALM2;CALCRL
58,prerank,MSigDB_Hallmark_2020__IL-2/STAT5 Signaling,0.5331391470134098,1.395557755026717,0.022653721682847898,0.1942038510480612,0.995,21/75,11.66%,CSF1;IL1R2;CST7;GBP4;PLIN2;CISH;CCND3;SPP1;NT5E;IFNGR1;SOCS1;IL4R;NFIL3;CXCL10;RHOH;TNFSF10;CASP3;F2RL2;SYNGR2;ODC1;MXD1
59,prerank,KEGG_2021_Human__Tuberculosis,0.5152920088165996,1.3934783708930152,0.0189873417721519,0.1924722777676786,0.995,35/89,19.11%,CD14;LSP1;CLEC7A;CLEC4E;MAPK13;LBP;FCGR2B;CEBPB;IFNGR1;TNFRSF1A;TCIRG1;IL10RB;CASP3;STAT1;BAX;TLR2;TIRAP;CTSD;RELA;SYK;TLR4;LAMP2;RIPK2;BID;NOD2;RAB7A;MYD88;RAB5A;CTSS;ATP6V0B;RHOA;CYCS;IFNGR2;RAB5C;CAMP
60,prerank,KEGG_2021_Human__Human immunodeficiency virus 1 infection,0.5171098117046679,1.3914384002555371,0.01780104712041885,0.19150021503850742,0.995,31/94,18.97%,BST2;ELOB;TAP1;CFL1;TAP2;FAS;MAPK13;TRIM5;BAK1;CGAS;TNFRSF1A;GNB2;CASP3;B2M;BAX;TLR2;LIMK2;RELA;TRAF5;CCR5;TLR4;BID;ELOC;MYD88;RIPK1;GNB1;NFKBIA;TRAF2;CYCS;STING1;MAP2K3
61,prerank,KEGG_2021_Human__Ubiquitin mediated proteolysis,0.5305743649538487,1.3775766919151216,0.039301310043668124,0.21367608486768638,0.997,21/65,19.49%,UBE2L6;ELOB;UBB;UBA7;SOCS1;PML;BIRC3;UBE2M;UBE2L3;UBE2Q1;UBE2I;UBE2F;CDC34;ELOC;SOCS3;UBE2J2;UBE2B;KEAP1;UBC;UBE2G2;UBE2Z
62,prerank,KEGG_2021_Human__Inflammatory bowel disease,0.6215946541877105,1.3637438029967137,0.09230769230769231,0.23794680037033433,0.999,8/19,18.16%,IFNGR1;IL4R;STAT1;TLR2;RELA;TLR4;NOD2;IFNGR2
63,prerank,KEGG_2021_Human__Spliceosome,-0.36769027622286843,-1.3608947944595438,0.0196078431372549,0.2490324751808851,0.796,26/91,17.45%,SRSF6;HNRNPA1L2;SRSF3;CRNKL1;SRSF9;SNRPF;SNRPA1;LSM2;HSPA2;HSPA8;SNRNP70;SRSF2;SNRPD3;ACIN1;SF3B1;CDC40;NCBP2;RBMX;DHX15;RP9;HNRNPM;SRSF7;BCAS2;SRSF1;LSM5;DDX5
64,prerank,KEGG_2021_Human__Neuroactive ligand-receptor interaction,0.6061659160777568,1.3568317750588765,0.08578745198463508,0.24688052585480325,1.0,13/23,25.23%,P2RY2;GPR35;TSPO;PTAFR;F2RL2;CYSLTR1;FPR1;CNR2;C3AR1;PTGER2;LTB4R;P2RY1;S1PR4
65,prerank,KEGG_2021_Human__Gastric acid secretion,-0.5043843607021551,-1.3530747692426877,0.1016949152542373,0.2501338473069922,0.809,7/17,9.02%,PRKACB;GNAS;PLCB2;CALM3;ADCY7;CALM2;CA2
66,prerank,KEGG_2021_Human__cGMP-PKG signaling pathway,-0.4120385829340158,-1.3514570301953965,0.06722689075630252,0.2412044860961745,0.813,12/44,13.01%,SLC25A4;PPP3CB;SLC25A5;PLCB2;CALM3;ADCY7;CALM2;ADRB2;AKT1;ATP2A3;MEF2C;VDAC3
67,prerank,KEGG_2021_Human__Viral carcinogenesis,0.49854605073114533,1.3504685892850392,0.048179871520342615,0.25462643155789855,1.0,24/88,19.74%,IRF7;CDKN1A;IRF9;TBPL1;CCND3;PKM;EGR2;EIF2AK2;BAK1;GSN;CASP3;BAX;LTBR;RELA;SYK;TRAF5;CCR5;NFKBIA;TRAF2;YWHAH;RHOA;MAPKAPK2;SNW1;CDC42
68,prerank,KEGG_2021_Human__HIF-1 signaling pathway,0.5332307702402708,1.3479399024779817,0.06877113866967305,0.25493586146392355,1.0,18/51,14.24%,ELOB;CDKN1A;LDHA;HMOX1;MKNK1;IFNGR1;TIMP1;ALDOA;PFKL;HK3;LDHC;EGLN2;PGK1;SLC2A1;LTBR;RELA;TLR4;ELOC
69,prerank,MSigDB_Hallmark_2020__E2F Targets,-0.3914138951440417,-1.347455058159357,0.0392156862745098,0.23655280722418534,0.822,23/60,17.97%,CDC25B;TUBB;PNN;RBBP7;GSPT1;ANP32E;SMC3;NAP1L1;CDKN1B;SMC6;RAD21;PA2G4;SMC4;SRSF2;NOP56;LUC7L3;XPO1;USP1;RANBP1;SRSF1;STMN1;SMC1A;NUP107
70,prerank,KEGG_2021_Human__Staphylococcus aureus infection,0.6007445226641053,1.3438135438978396,0.10821382007822686,0.25916912592294633,1.0,9/21,11.24%,C2;FCAR;C1QB;FCGR2B;C1QA;PTAFR;ICAM1;SELPLG;FPR1
71,prerank,KEGG_2021_Human__p53 signaling pathway,0.5700799483882265,1.339641230550517,0.0967741935483871,0.2631436329758226,1.0,6/28,8.31%,SHISA5;CDKN1A;CCND3;FAS;CASP3;BAX
72,prerank,KEGG_2021_Human__Cell cycle,-0.40369932780685136,-1.3371971848194704,0.07142857142857142,0.24160188457008247,0.836,9/38,8.52%,CDC25B;ANAPC13;SMAD4;SMC3;RBL2;CDKN1B;RAD21;ANAPC4;ANAPC5
73,prerank,KEGG_2021_Human__Lipid and atherosclerosis,0.49049056567169824,1.3348855381443092,0.039832285115303984,0.2676659902281218,1.0,35/101,19.74%,IRF7;CD14;FAS;NCF2;MAPK13;DDIT3;LBP;CXCL3;CCL3L3;TNFRSF1A;SOD2;NCF4;TNFSF10;CASP3;ICAM1;BAX;TLR2;VAV1;CCL2;TIRAP;CASP1;RELA;TLR4;BID;ABCA1;MYD88;RAP1B;NFKBIA;TRAF2;RHOA;CYCS;ABCG1;MAP2K3;CYBA;CDC42
74,prerank,KEGG_2021_Human__Lysine degradation,-0.4921030882581318,-1.328882301920863,0.13656387665198239,0.2447222977258313,0.845,11/20,23.82%,EZH1;NSD1;PRDM2;SETD2;KMT2A;ECHS1;KMT2B;KMT5B;COLGALT1;ALDH2;KMT5A
75,prerank,KEGG_2021_Human__Pathogenic Escherichia coli infection,0.4912597335887072,1.3241363775153265,0.04807692307692308,0.2860672604980913,1.0,32/90,21.59%,PTPN6;ACTG1;TMBIM6;FAS;MAPK13;BAK1;TUBA4A;TNFRSF1A;TNFSF10;CASP3;BAX;ARPC3;CLDN1;TIRAP;ARPC1B;HCLS1;CASP1;NFKBIB;SLC9A3R1;RELA;TLR4;CLDN5;MYD88;RIPK1;NFKBIA;TRAF2;RHOA;CYCS;ARPC1A;CDC42;ARPC5;TUBA1C
76,prerank,KEGG_2021_Human__Human papillomavirus infection,0.48320312502293816,1.322071627618808,0.03556485355648536,0.2853577424425506,1.0,27/114,13.26%,ISG15;OASL;MX1;CDKN1A;IRF9;ATP6V1F;STAT2;TBPL1;CCND3;ATP6V1G1;PKM;FAS;IFNAR2;EIF2AK2;SPP1;BAK1;TNFRSF1A;TCIRG1;CASP3;STAT1;BAX;ATP6V1B2;RHEB;SLC9A3R1;IRF1;RELA;ATP6V0E1
77,prerank,MSigDB_Hallmark_2020__Myogenesis,0.5362910787364521,1.3187005046401694,0.09824561403508772,0.28695656733740715,1.0,11/41,15.80%,CDKN1A;LSP1;BAG1;IFRD1;GSN;HBEGF;SYNGR2;RIT1;TPM3;SIRT2;PDLIM7
78,prerank,KEGG_2021_Human__Alcoholism,-0.3907576150784575,-1.3081608787462085,0.07692307692307693,0.26628277276098244,0.876,7/45,8.81%,PRKACB;FOSB;GNAS;HDAC9;CALM3;CALM2;H2AZ2
79,prerank,KEGG_2021_Human__Toxoplasmosis,0.510035204513596,1.3061767026584268,0.08532423208191127,0.3112482121603962,1.0,20/53,18.97%,MAPK13;IFNGR1;SOCS1;TNFRSF1A;IL10RB;IRGM;BIRC3;CASP3;STAT1;TLR2;NFKBIB;RELA;CCR5;TLR4;PIK3R5;MYD88;NFKBIA;CYCS;IFNGR2;MAP2K3
80,prerank,KEGG_2021_Human__PPAR signaling pathway,0.5823086485560927,1.3026448048623538,0.12132822477650064,0.31378739219131874,1.0,7/22,17.51%,FABP5;PLIN2;CPT1A;PLIN5;SCP2;UBC;ACSL5
81,prerank,MSigDB_Hallmark_2020__Complement,0.4890287754549978,1.3006020893190195,0.06944444444444445,0.312639850605675,1.0,28/87,15.55%,IRF7;PSMB9;C2;PLAUR;LGALS3;PPP4C;RHOG;CSRP1;CEBPB;CTSB;SERPING1;C1QA;TIMP1;GNB2;CASP3;CTSD;CASP1;USP15;MSRB1;IRF1;DOCK4;GCA;LAMP2;PIK3R5;FDX1;EHD1;CTSS;LGMN
82,prerank,KEGG_2021_Human__Antigen processing and presentation,0.5559891357301164,1.292718878867239,0.13468869123252858,0.32636014231178745,1.0,8/27,15.55%,PSME2;TAP1;TAP2;PSME1;CTSB;B2M;CTSS;LGMN
83,prerank,MSigDB_Hallmark_2020__Glycolysis,0.49344509524054847,1.2687757111003497,0.12017640573318633,0.38137085123279024,1.0,12/63,9.74%,ISG20;TPI1;GNPDA1;SLC16A3;LDHA;PKM;NT5E;TALDO1;ALDOA;SAP30;LDHC;PGK1
84,prerank,KEGG_2021_Human__Amino sugar and nucleotide sugar metabolism,0.5717911427458708,1.2629765696653494,0.18503937007874016,0.3904744591892383,1.0,5/19,12.72%,NPL;GNPDA1;HK3;AMDHD2;PMM1
85,prerank,KEGG_2021_Human__Systemic lupus erythematosus,0.5482537299278738,1.2563322002440154,0.1675,0.4020304474687191,1.0,5/24,6.41%,CD80;C2;TRIM21;C1QB;C1QA
86,prerank,KEGG_2021_Human__Circadian entrainment,-0.45005600310800276,-1.2550631386998485,0.1642512077294686,0.3493185259969713,0.942,7/21,11.22%,PRKACB;GNAS;PLCB2;CALM3;ADCY7;CALM2;FOS
87,prerank,KEGG_2021_Human__Fluid shear stress and atherosclerosis,0.49604896499221807,1.2533477875268617,0.12009237875288684,0.4029740047264133,1.0,12/55,12.51%,IL1R2;SQSTM1;ACTG1;HMOX1;NCF2;MAPK13;TNFRSF1A;ICAM1;CCL2;SDC4;GSTP1;RELA
88,prerank,KEGG_2021_Human__Human cytomegalovirus infection,0.45364630979218246,1.235131590724874,0.1092436974789916,0.4486750546100411,1.0,30/102,18.47%,CDKN1A;TAP1;TAP2;FAS;MAPK13;BAK1;CGAS;CCL3L3;TNFRSF1A;IL10RB;GNB2;CCL4L2;CASP3;B2M;BAX;CCL2;RHEB;RELA;TRAF5;CCR5;BID;CCR1;CXCR2;RIPK1;GNB1;NFKBIA;TRAF2;RHOA;CYCS;STING1
89,prerank,KEGG_2021_Human__Cushing syndrome,-0.3852363457929013,-1.2330498092441786,0.13768115942028986,0.38032573819097526,0.962,9/38,11.93%,PRKACB;TCF7;LDLR;GNAS;PLCB2;CDKN1B;ADCY7;APC;FH
90,prerank,MSigDB_Hallmark_2020__UV Response Dn,-0.39891505749242595,-1.232260155453383,0.13297872340425532,0.37055359246171965,0.962,7/32,11.89%,NEK7;LDLR;PIK3CD;CDKN1B;ZMIZ1;PRDM2;NIPBL
91,prerank,MSigDB_Hallmark_2020__mTORC1 Signaling,0.4478589130211262,1.219495696765363,0.12643678160919541,0.4885271592848221,1.0,28/112,19.13%,CDKN1A;SQSTM1;TPI1;WARS1;LDHA;NAMPT;IFRD1;DDIT3;SLA;TUBA4A;NFIL3;ALDOA;PFKL;PGK1;SLC2A1;TRIB3;DAPP1;RIT1;ADIPOR2;NFKBIB;SLC9A3R1;TES;LGMN;SERP1;RDH11;GGA2;MAP2K3;SEC11A
92,prerank,KEGG_2021_Human__Endocytosis,0.4383831202284457,1.2060058731149428,0.13003095975232198,0.522934358255209,1.0,36/119,22.22%,CLTA;ARF5;SNF8;DAB2;VPS29;WASHC2C;SH3GLB1;PML;ARPC3;TSG101;ARPC1B;RAB11A;MVB12A;VPS26A;CHMP5;CCR5;CHMP2A;SMAP2;RAB7A;RAB5A;CXCR2;EHD1;EPN1;RAB8A;RNF103-CHMP3;VPS37C;RHOA;ARPC1A;RAB5C;ARRB2;CDC42;VPS28;VPS25;ARPC5;ARF4;CAPZB
93,prerank,KEGG_2021_Human__Sphingolipid metabolism,-0.46565191752069107,-1.2003392025420867,0.22014925373134328,0.42562407386298867,0.976,3/15,2.02%,SGMS1;PSAP;CERK
94,prerank,KEGG_2021_Human__RNA degradation,-0.3773978199486385,-1.1966452301250619,0.11688311688311688,0.4205683156654888,0.976,6/37,8.14%,PARN;TOB1;PABPC1;HSPD1;LSM2;TENT4B
95,prerank,MSigDB_Hallmark_2020__p53 Pathway,0.43912654998019335,1.1955509418045562,0.15256008359456635,0.547852095073623,1.0,25/105,14.66%,TRAFD1;CDKN1A;TAP1;UPP1;RALGDS;PRKAB1;CCND3;HMOX1;FAS;DDIT3;BAK1;PTPRE;SOCS1;ATF3;BAX;SLC3A2;HBEGF;TRIB3;CTSD;VAMP8;CASP1;MXD1;PMM1;STOM;SERTAD3
96,prerank,KEGG_2021_Human__Chemical carcinogenesis,-0.3284190568007531,-1.1947189261504996,0.12903225806451613,0.412106935075133,0.979,11/63,11.22%,PRKACB;KLF4;GNAS;RPS6KA3;PIK3CD;GSTK1;ADCY7;ADRB2;AKT1;RPS6KB1;FOS
97,prerank,MSigDB_Hallmark_2020__Pperoxisome,-0.3583071530979094,-1.191542668967437,0.1393939393939394,0.4077461373241877,0.982,12/41,13.62%,SLC25A4;IDH2;CAT;ELOVL5;GSTK1;PABPC1;DHRS3;SMARCC1;CTBP1;SCGB1A1;PRDX1;ABCD1
98,prerank,KEGG_2021_Human__Salmonella infection,0.4313735428324222,1.1913313601006748,0.14124872057318322,0.5520880119698517,1.0,45/137,21.78%,CD14;GSDMD;ARL8A;DYNLT1;ACTG1;RHOG;MAPK13;BAK1;TUBA4A;TNFRSF1A;MYL12A;RHOH;BIRC3;TNFSF10;CASP3;BAX;TLR2;ARPC3;TIRAP;ARPC1B;CASP1;RELA;TLR4;RIPK2;RAB7A;VPS18;MYD88;RAB5A;RIPK1;DCTN5;NFKBIA;TRAF2;MYL12B;RHOA;CYCS;ARPC1A;PFN1;RAB5C;MAP2K3;CDC42;FYCO1;ARPC5;TUBA1C;KPNA4;TXN2
99,prerank,KEGG_2021_Human__C-type lectin receptor signaling pathway,0.4637182556379663,1.191195328059192,0.19176598049837487,0.5441663499198494,1.0,19/58,20.74%,LSP1;IRF9;STAT2;CLEC7A;CLEC4E;EGR2;MAPK13;STAT1;CASP1;IRF1;RELA;SYK;BCL3;NFKBIA;RHOA;RELB;MAPKAPK2;FCER1G;CLEC4D
100,prerank,KEGG_2021_Human__RNA transport,-0.3268047299655582,-1.1822894754873485,0.14473684210526316,0.41595153962645126,0.985,15/77,15.30%,EEF1A1;PNN;EIF4G3;PABPC1;EIF3F;EIF3E;TRNT1;EIF4A2;ACIN1;THOC7;UPF3B;NCBP2;SEH1L;ELAC1;XPO1
101,prerank,KEGG_2021_Human__GnRH signaling pathway,-0.3869951332912894,-1.1821085744988986,0.19101123595505617,0.4046590760371679,0.986,6/28,8.56%,PRKACB;GNAS;PLCB2;CALM3;ADCY7;CALM2
102,prerank,KEGG_2021_Human__Transcriptional misregulation in cancer,0.4578326626564091,1.1820206525734833,0.20750551876379691,0.5660345337482737,1.0,16/66,13.41%,CD14;IL1R2;CDKN1A;DDIT3;BAK1;CEBPB;PML;MAX;BIRC3;CDK9;BAX;SPI1;ASPSCR1;BCL2A1;RELA;H3-3B
103,prerank,KEGG_2021_Human__Neutrophil extracellular trap formation,0.447319050550819,1.1719893470104685,0.21787709497206703,0.5898992963846145,1.0,16/60,13.41%,GSDMD;ACTG1;CLEC7A;NCF2;MAPK13;SIGLEC9;NCF4;TLR2;SELPLG;CASP1;FPR1;RELA;SYK;VDAC2;TLR4;H3-3B
104,prerank,KEGG_2021_Human__Apoptosis,0.44018623356675035,1.1680730761432818,0.21092077087794434,0.5948388830489317,1.0,23/76,18.09%,ACTG1;FAS;DDIT3;BAK1;TUBA4A;CTSB;TNFRSF1A;BIRC3;TNFSF10;CASP3;BAX;CTSD;LMNB1;BCL2A1;RELA;CFLAR;BID;CTSS;MCL1;RIPK1;NFKBIA;TRAF2;CYCS
105,prerank,MSigDB_Hallmark_2020__Reactive Oxygen Species Pathway,0.49044497221316286,1.1671694019288197,0.25060240963855424,0.5890749733814631,1.0,12/32,22.03%,LSP1;GCLM;SRXN1;SOD2;FTL;EGLN2;MSRA;CDKN2D;SBNO2;HMOX2;GCLC;FES
106,prerank,KEGG_2021_Human__Tight junction,0.45602809249596843,1.1626783461020127,0.23562570462232243,0.5949339556700318,1.0,19/53,21.59%,PRKAB1;ACTG1;TUBA4A;MYL12A;ARPC3;CLDN1;ARPC1B;MYL6;HCLS1;SLC9A3R1;CLDN5;VASP;RAB8A;MYL12B;RHOA;ARPC1A;CDC42;ARPC5;TUBA1C
107,prerank,KEGG_2021_Human__Fc epsilon RI signaling pathway,0.49094759102159374,1.1608128568033773,0.2646341463414634,0.5926786038902018,1.0,13/29,27.88%,ALOX5AP;MAPK13;VAV1;SYK;BTK;MAP2K3;LCP2;FCER1G;LYN;RAC2;RAF1;NRAS;VAV3
108,prerank,KEGG_2021_Human__Natural killer cell mediated cytotoxicity,0.46044531848925924,1.1464944144672355,0.26936416184971096,0.6301857943636648,1.0,16/40,20.30%,PTPN6;FAS;IFNAR2;IFNGR1;TNFSF10;CASP3;ICAM1;HCST;VAV1;SYK;BID;IFNGR2;TYROBP;SH3BP2;LCP2;FCER1G
109,prerank,MSigDB_Hallmark_2020__Xenobiotic Metabolism,0.4451057866227574,1.1410881134192932,0.2777777777777778,0.6389918049298163,1.0,17/59,18.93%,UPP1;HMOX1;TMBIM6;FAS;LPIN2;ETS2;TNFRSF1A;GCH1;POR;SAR1B;PMM1;SERTAD1;SLC46A3;ARG1;XDH;PTGES;GABARAPL1
110,prerank,MSigDB_Hallmark_2020__KRAS Signaling Dn,0.543568112460169,1.1365039528669612,0.31733333333333336,0.6465297218687512,1.0,3/15,1.89%,MX1;RSAD2;CD80
111,prerank,KEGG_2021_Human__Prolactin signaling pathway,0.4672444736684282,1.1361486892913464,0.2917166866746699,0.6391256613630057,1.0,8/33,18.36%,CISH;MAPK13;SOCS1;STAT1;IRF1;RELA;SOCS3;SOCS2
112,prerank,KEGG_2021_Human__Chemokine signaling pathway,0.42550481190063605,1.1332985719092799,0.2609625668449198,0.6395956343238655,1.0,33/79,25.07%,CXCL16;STAT2;CXCL3;CCR9;CCL3L3;CCL8;GNB2;CXCL10;CCL4L2;STAT1;VAV1;CCL2;NFKBIB;RELA;CCR5;FGR;PIK3R5;CCR1;CXCR2;RAP1B;GNB1;NFKBIA;CXCL11;RHOA;ARRB2;CDC42;GNG11;LYN;RAC2;PRKCD;GNAI3;CRK;CCL5
113,prerank,KEGG_2021_Human__Complement and coagulation cascades,0.5260826209980506,1.1278778892739036,0.3174193548387097,0.6484579726762967,1.0,6/19,8.16%,C2;PLAUR;C1QB;SERPING1;C1QA;F2RL2
114,prerank,KEGG_2021_Human__Thyroid hormone signaling pathway,-0.3185126790391121,-1.125846580163629,0.2125984251968504,0.5277432909941744,0.991,8/47,11.35%,PRKACB;NCOA3;FOXO1;PIK3CD;PLCB2;SIN3A;AKT1;ATP2A3
115,prerank,KEGG_2021_Human__Mitophagy,0.45637917633969355,1.1222876746771526,0.29591836734693877,0.658066887723521,1.0,18/42,29.46%,UBB;SQSTM1;GABARAP;CSNK2B;USP15;RELA;BNIP3L;RAB7A;OPTN;UBC;GABARAPL1;TFE3;BECN1;ATG9A;EIF2AK3;NRAS;TBK1;HIF1A
116,prerank,KEGG_2021_Human__IL-17 signaling pathway,0.4536608003266409,1.120760113865884,0.3075117370892019,0.6545757589529178,1.0,14/40,22.90%,MAPK13;LCN2;CXCL3;CEBPB;CXCL10;CASP3;CCL2;RELA;TRAF5;NFKBIA;TRAF2;IL17RA;MMP9;TNFAIP3
117,prerank,KEGG_2021_Human__Inflammatory mediator regulation of TRP channels,-0.37536953779449234,-1.1123985379162715,0.27692307692307694,0.5504928398735355,0.992,7/24,8.56%,PRKACB;GNAS;PIK3CD;PLCB2;CALM3;ADCY7;CALM2
118,prerank,KEGG_2021_Human__Melanoma,0.46508967651978217,1.1018593298652584,0.3542926239419589,0.706182714253974,1.0,3/28,8.31%,CDKN1A;BAK1;BAX
119,prerank,KEGG_2021_Human__Central carbon metabolism in cancer,0.46217089284482177,1.1014265163489965,0.3473557692307692,0.6989786779343888,1.0,7/33,9.76%,SLC16A3;LDHA;PKM;PFKL;HK3;LDHC;SLC2A1
120,prerank,KEGG_2021_Human__Renal cell carcinoma,0.4515661782080443,1.09960258434338,0.34414831981460026,0.6961497690452777,1.0,13/39,27.67%,ELOB;CDKN1A;EGLN2;SLC2A1;ELOC;RAP1B;RAPGEF1;FLCN;CDC42;CRK;TFE3;RAF1;NRAS
121,prerank,MSigDB_Hallmark_2020__Epithelial Mesenchymal Transition,0.4494565563333776,1.0983407017618072,0.3341121495327103,0.6919008232269458,1.0,9/38,7.29%,INHBA;PLAUR;MGP;FAS;SPP1;NT5E;DAB2;TIMP1;TPM4
122,prerank,KEGG_2021_Human__Cholinergic synapse,-0.35132445177463795,-1.0979896577544417,0.2929936305732484,0.5752166953580382,0.996,6/32,11.22%,PRKACB;PIK3CD;PLCB2;ADCY7;AKT1;FOS
123,prerank,KEGG_2021_Human__Shigellosis,0.40127941748321383,1.097118632375225,0.3062692702980473,0.6879193087887764,1.0,36/125,18.93%,CD14;UBB;SQSTM1;ACTG1;MAPK13;RRAGC;GABARAP;UBE2V1;CGAS;TNFRSF1A;MYL12A;BAX;ARPC3;HK3;ARPC1B;HCLS1;CASP1;NFKBIB;RELA;TRAF5;TLR4;H3-3B;RIPK2;RBCK1;MYD88;RIPK1;NFKBIA;UBC;TRAF2;MYL12B;RHOA;CYCS;STING1;ARPC1A;PFN1;GABARAPL1
124,prerank,KEGG_2021_Human__Bladder cancer,0.4862045286056199,1.0937584391582218,0.3614303959131545,0.689970322520641,1.0,8/22,28.98%,CDKN1A;HBEGF;THBS1;MMP9;RASSF1;RAF1;NRAS;E2F2
125,prerank,KEGG_2021_Human__Wnt signaling pathway,-0.3372724524590593,-1.087320578744129,0.2805755395683453,0.592226148409894,0.996,6/36,6.45%,PRKACB;TCF7;SMAD4;PPP3CB;RUVBL1;PLCB2
126,prerank,KEGG_2021_Human__AGE-RAGE signaling pathway in diabetic complications,-0.32785195673629997,-1.082700393634199,0.3064516129032258,0.5911689505587636,0.997,7/43,6.72%,FN1;FOXO1;THBD;SMAD4;PIK3CD;PLCB2;CDKN1B
127,prerank,KEGG_2021_Human__Vibrio cholerae infection,0.48354469485685725,1.0808518605449366,0.380352644836272,0.7222232321396109,1.0,9/21,16.84%,ATP6V1F;ACTG1;ATP6V1G1;TCIRG1;ATP6V1B2;ATP6V0E1;KDELR1;ATP6V0B;ATP6V1C1
128,prerank,MSigDB_Hallmark_2020__Estrogen Response Late,0.42557959322922473,1.0780556844519467,0.36291240045506257,0.7226965964865891,1.0,9/53,8.49%,FABP5;ISG20;PTPN6;BAG1;CISH;MAPK13;CHPT1;SNX10;ITPK1
129,prerank,KEGG_2021_Human__Fc gamma R-mediated phagocytosis,0.42920835378780314,1.0707574738110732,0.38002296211251435,0.7373753291025739,1.0,17/44,24.71%,CFL1;FCGR2B;GSN;MARCKSL1;ARPC3;VAV1;LIMK2;ARPC1B;SYK;VASP;ARPC1A;CDC42;ARPC5;LYN;RAC2;PRKCD;CRK
130,prerank,KEGG_2021_Human__Autophagy,0.4065651129275283,1.0625168866178383,0.38804347826086955,0.753739926074047,1.0,29/69,29.46%,SQSTM1;RRAGC;GABARAP;CTSB;SH3GLB1;RHEB;CTSD;VAMP8;CFLAR;LAMP2;ATG3;RAB7A;RAB8A;GABARAPL1;VMP1;PRKCD;PPP2CA;LAMP1;BECN1;ATG12;ATG9A;RAF1;EIF2AK3;NRAS;ITPR1;TBK1;PPP2CB;RRAGA;HIF1A
131,prerank,KEGG_2021_Human__Pathways of neurodegeneration,0.3776110286287855,1.0612782847392725,0.3629032258064516,0.7490285482559615,1.0,48/217,20.32%,UBE2L6;CSF1;UBB;UBA7;SQSTM1;PSMA5;UQCRHL;FAS;MAPK13;DDIT3;GABARAP;BAK1;CSNK2B;TUBA4A;TNFRSF1A;TPTEP2-CSNK1E;PSMD8;CASP3;BAX;PSMA1;ATP5PO;PSMB3;UBE2L3;RELA;VDAC2;BID;NDUFA7;UBE2J2;CSNK1A1L;RAB5A;ADRM1;PSMA6;OPTN;DCTN5;RAB8A;UBC;NDUFS4;TRAF2;CYCS;DVL2;DERL1;GABARAPL1;MAP2K3;UBE2G2;COX8A;PSMA2;NDUFS6;MCU
132,prerank,MSigDB_Hallmark_2020__Coagulation,0.4296360760266791,1.0542265450157928,0.40420560747663553,0.76252983647242,1.0,20/39,23.24%,C2;CSRP1;CTSB;SERPING1;C1QA;TIMP1;GNB2;GSN;F2RL2;LAMP2;SIRT2;LGMN;CTSE;THBS1;ANXA1;ARF4;PLEK;MMP9;MAFF;P2RY1
133,prerank,KEGG_2021_Human__T cell receptor signaling pathway,-0.31106867778277836,-1.053746611889136,0.3870967741935484,0.6621235066464749,0.999,5/44,4.54%,CD3D;MALT1;CD3E;PPP3CB;PIK3CD
134,prerank,KEGG_2021_Human__PD-L1 expression and PD-1 checkpoint pathway in cancer,0.4086197340619661,1.052888147932145,0.3973509933774834,0.7584884859644289,1.0,16/53,18.97%,CD274;PTPN6;MAPK13;CSNK2B;IFNGR1;STAT1;TLR2;TIRAP;BATF2;NFKBIB;RELA;TLR4;MYD88;NFKBIA;IFNGR2;MAP2K3
135,prerank,KEGG_2021_Human__Dopaminergic synapse,-0.332637967768135,-1.0515669934586287,0.3880597014925373,0.654066343440984,0.999,8/40,11.22%,PRKACB;GNAS;PPP3CB;PLCB2;CALM3;CALM2;AKT1;FOS
136,prerank,KEGG_2021_Human__Leukocyte transendothelial migration,0.416280096907727,1.0359879277523125,0.42406542056074764,0.8000778388455484,1.0,22/46,26.61%,ACTG1;NCF2;MAPK13;MYL12A;NCF4;RHOH;ICAM1;VAV1;CLDN1;CLDN5;VASP;RAP1B;MYL12B;RHOA;CYBA;CDC42;MMP9;RAC2;GNAI3;RASSF5;ACTB;EZR
137,prerank,KEGG_2021_Human__Apelin signaling pathway,-0.3022414827207955,-1.0352648775299471,0.3855421686746988,0.6878680800942284,1.0,10/52,11.03%,RPS6;PRKACB;SMAD4;PLCB2;CALM3;ADCY7;CALM2;AKT1;RRAS;RPS6KB1
138,prerank,KEGG_2021_Human__Glycerolipid metabolism,0.4856047299445284,1.0315030180654103,0.4484605087014726,0.805032386456051,1.0,5/16,21.42%,LPIN2;DGAT2;PNPLA2;LPIN1;DGAT1
139,prerank,KEGG_2021_Human__mTOR signaling pathway,0.4047179832579806,1.0302151695465567,0.4435840707964602,0.8001803649336485,1.0,16/57,18.74%,FNIP2;ATP6V1F;ATP6V1G1;RRAGC;LPIN2;TNFRSF1A;ATP6V1B2;SLC3A2;RHEB;RPS6KA1;ATP6V1C1;FLCN;RHOA;DVL2;LAMTOR1;LPIN1
140,prerank,KEGG_2021_Human__Th17 cell differentiation,-0.31338492606292145,-1.024206495290533,0.4068965517241379,0.7077084151289098,1.0,5/39,5.14%,CD3D;CD3E;SMAD4;PPP3CB;HLA-DRA
141,prerank,MSigDB_Hallmark_2020__G2-M Checkpoint,-0.28434484196703524,-1.0208730976231053,0.38613861386138615,0.7035386900189482,1.0,21/71,17.68%,CDC25B;GSPT1;DR1;NUMA1;CDKN1B;RAD21;HSPA8;G3BP1;H2AZ2;SMARCC1;SMC4;SRSF2;SFPQ;CUL5;PRPF4B;HMGN2;XPO1;CBX1;SRSF1;STMN1;SMC1A
142,prerank,KEGG_2021_Human__Glutathione metabolism,0.4598325112104731,1.0181668088858469,0.46894803548795944,0.8269856277302908,1.0,5/20,12.10%,GCLM;TXNDC12;GGCT;ODC1;GSTP1
143,prerank,KEGG_2021_Human__Longevity regulating pathway,-0.29799579504030416,-1.0162839771623902,0.4393939393939394,0.7033556374207454,1.0,9/46,11.03%,PRKACB;FOXO1;CAT;PIK3CD;ADCY7;HSPA2;HSPA8;AKT1;RPS6KB1
144,prerank,KEGG_2021_Human__N-Glycan biosynthesis,-0.39006190067500424,-1.0157232479782552,0.4156378600823045,0.690616411464468,1.0,1/17,0.19%,ST6GAL1
145,prerank,KEGG_2021_Human__Hypertrophic cardiomyopathy,-0.3852703959274896,-1.015115999007574,0.3953488372093023,0.678589456984207,1.0,4/16,5.02%,ITGA4;LMNA;ITGB7;ITGB1
146,prerank,KEGG_2021_Human__Hematopoietic cell lineage,0.438315252325048,1.0139062471131202,0.45454545454545453,0.830876482569032,1.0,5/26,6.29%,CSF1;CD14;IL1R2;CSF2RA;IL4R
147,prerank,KEGG_2021_Human__Small cell lung cancer,0.4103499485983913,1.012845055865404,0.46808510638297873,0.8253033883646499,1.0,11/38,18.09%,CDKN1A;BAK1;MAX;BIRC3;CASP3;BAX;RELA;TRAF5;NFKBIA;TRAF2;CYCS
148,prerank,KEGG_2021_Human__Proteoglycans in cancer,0.37947080739094985,0.9971863316714513,0.5076086956521739,0.8625509907289585,1.0,13/73,10.58%,CDKN1A;PTPN6;CD63;ACTG1;PLAUR;FAS;MAPK13;CASP3;TLR2;VAV1;HBEGF;HCLS1;SDC4
149,prerank,KEGG_2021_Human__Bacterial invasion of epithelial cells,-0.3183610284331494,-0.9959048264035185,0.47468354430379744,0.7236277974087162,1.0,6/35,5.02%,FN1;SEPTIN11;WASF2;ELMO2;PIK3CD;ITGB1
150,prerank,KEGG_2021_Human__Basal transcription factors,0.4577048660664836,0.9936686707284516,0.49801849405548215,0.863719287762261,1.0,2/18,5.56%,TBPL1;TAF12
151,prerank,KEGG_2021_Human__Chagas disease,0.3902362835840355,0.9936619045236909,0.5123873873873874,0.8552592042088605,1.0,15/54,18.16%,FAS;MAPK13;C1QB;IFNGR1;CCL3L3;TNFRSF1A;C1QA;TLR2;CCL2;RELA;CFLAR;TLR4;MYD88;NFKBIA;IFNGR2
152,prerank,KEGG_2021_Human__Legionellosis,0.41660698585581923,0.9850329194931015,0.4969097651421508,0.8714080229013965,1.0,12/31,18.09%,CD14;CXCL3;CASP3;TLR2;SAR1B;CASP1;RELA;TLR4;MYD88;SAR1A;NFKBIA;CYCS
153,prerank,KEGG_2021_Human__Inositol phosphate metabolism,-0.317430741513631,-0.9802847221838976,0.4835164835164835,0.7596480288228366,1.0,6/28,10.06%,MTMR1;PIK3CD;INPP4A;PLCB2;MTMR6;IMPA1
154,prerank,KEGG_2021_Human__Pancreatic cancer,0.39071066488472994,0.9736604004630031,0.5293440736478712,0.8940286206703676,1.0,6/44,12.51%,CDKN1A;RALGDS;BAK1;STAT1;BAX;RELA
155,prerank,KEGG_2021_Human__Insulin signaling pathway,-0.2745504719933577,-0.965683165000234,0.5510204081632653,0.7897526501766784,1.0,9/53,11.03%,RPS6;PRKACB;FOXO1;PIK3CD;CALM3;MKNK2;CALM2;AKT1;RPS6KB1
156,prerank,KEGG_2021_Human__Lysosome,0.37361751591396797,0.9646780980163643,0.5580110497237569,0.910163346923936,1.0,20/64,20.01%,CLTA;CD63;CTSB;TCIRG1;NAPSA;HYAL2;CTSD;LITAF;LAPTM4A;PPT1;LAMP2;CLN3;SMPD1;CTSS;LGMN;ATP6V0B;CTSE;GGA2;CD164;CLN5
157,prerank,KEGG_2021_Human__Morphine addiction,-0.3693669316888998,-0.9566740911725548,0.5126050420168067,0.8042758406115964,1.0,3/16,7.56%,PRKACB;GNAS;ADCY7
158,prerank,KEGG_2021_Human__Leishmaniasis,0.3888078193338862,0.9508303673547764,0.5812574139976275,0.9382728869193593,1.0,15/41,19.47%,PTPN6;NCF2;MAPK13;IFNGR1;NCF4;MARCKSL1;STAT1;TLR2;NFKBIB;RELA;TLR4;MYD88;NFKBIA;IFNGR2;CYBA
159,prerank,MSigDB_Hallmark_2020__Fatty Acid Metabolism,0.3690391171092879,0.946907888797277,0.5908071748878924,0.939325730071168,1.0,15/60,19.57%,UBE2L6;PSME1;LDHA;CPT1A;ALDOA;MCEE;CA4;ODC1;ADIPOR2;HMGCL;ACSL5;YWHAH;RDH11;GABARAPL1;HPGD
160,prerank,KEGG_2021_Human__Breast cancer,-0.28951115551220824,-0.9456854791055971,0.5384615384615384,0.8250665270688827,1.0,8/41,11.66%,NCOA3;TCF7;HES1;PIK3CD;AKT1;RPS6KB1;FOS;APC
161,prerank,KEGG_2021_Human__Pathways in cancer,0.33833089127279237,0.9451583981415297,0.6286579212916246,0.935160526368943,1.0,39/167,18.30%,ELOB;CDKN1A;RALGDS;STAT2;CSF2RA;CCND3;HMOX1;FAS;IFNAR2;BAK1;IFNGR1;IL4R;GNB2;PML;MAX;BIRC3;CASP3;STAT1;BAX;SPI1;EGLN2;SLC2A1;CSF3R;GSTP1;TPM3;IL15RA;RELA;TRAF5;BID;ELOC;IL13RA1;KEAP1;GNB1;NFKBIA;TRAF2;RHOA;CYCS;IFNGR2;DVL2
162,prerank,KEGG_2021_Human__FoxO signaling pathway,0.36439269270129465,0.9425331820814051,0.5925925925925926,0.9336326672881828,1.0,7/60,7.81%,CDKN1A;PRKAB1;MAPK13;GABARAP;SOD2;TPTEP2-CSNK1E;TNFSF10
163,prerank,KEGG_2021_Human__Colorectal cancer,0.3768096612984554,0.9390241895566782,0.5885714285714285,0.9340951232007403,1.0,5/44,8.31%,CDKN1A;RALGDS;BAK1;CASP3;BAX
164,prerank,KEGG_2021_Human__Glioma,0.39261836593272814,0.9376726700690352,0.5822328931572629,0.9292632297813173,1.0,3/31,8.31%,CDKN1A;BAK1;BAX
165,prerank,KEGG_2021_Human__Human T-cell leukemia virus 1 infection,0.3473978368182332,0.9376216749309444,0.6059009483667018,0.9211215655595087,1.0,17/92,13.16%,IL1R2;CDKN1A;TSPO;TBPL1;CCND3;EGR2;ETS2;TNFRSF1A;ICAM1;B2M;BAX;SPI1;SLC2A1;LTBR;IL15RA;RELA;VDAC2
166,prerank,KEGG_2021_Human__Amoebiasis,0.390376915045078,0.9367383944495803,0.5865384615384616,0.9152653660718163,1.0,11/31,18.80%,CD14;IL1R2;CXCL3;CASP3;TLR2;RELA;TLR4;RAB7A;RAB5A;ARG1;RAB5C
167,prerank,KEGG_2021_Human__B cell receptor signaling pathway,-0.27618448504238086,-0.9337473978198266,0.5339805825242718,0.8468572652318236,1.0,10/47,11.22%,IFITM1;MALT1;CR2;PPP3CB;PIK3CD;CD79A;CD22;CD79B;AKT1;FOS
168,prerank,KEGG_2021_Human__Pyruvate metabolism,0.4433665428365122,0.9311087526161665,0.5947712418300654,0.9211028616806515,1.0,3/15,9.49%,LDHA;PKM;LDHC
169,prerank,KEGG_2021_Human__Drug metabolism,0.43756014450467845,0.9308933322393624,0.5766710353866317,0.9135471021079171,1.0,4/17,17.78%,UPP1;IMPDH1;GSTP1;XDH
170,prerank,MSigDB_Hallmark_2020__Apical Junction,0.3651561185279941,0.9296674723887042,0.5966850828729282,0.9088620250863481,1.0,19/51,27.69%,CD274;ACTG1;ZYX;MAPK13;ICAM1;CAP1;SYK;CLDN5;VASP;YWHAH;MYL12B;PFN1;EVL;MMP9;RAC2;LIMA1;ACTB;STX4;FYB1
171,prerank,MSigDB_Hallmark_2020__Unfolded Protein Response,-0.2722099973023168,-0.9250310876988259,0.6727272727272727,0.8576476527006562,1.0,12/56,13.68%,PARN;SEC31A;KHSRP;NPM1;EEF2;SPCS3;EIF4A2;CXXC1;SPCS1;NOP56;HERPUD1;VEGFA
172,prerank,MSigDB_Hallmark_2020__Oxidative Phosphorylation,-0.23154969063646968,-0.9225037933954778,0.8148148148148148,0.8503295931229723,1.0,36/128,18.36%,SLC25A4;MRPS15;IDH2;PDHA1;COX7B;HTRA2;HSD17B10;SLC25A5;UQCRB;ACADM;NDUFB5;RHOT1;MDH1;UQCR10;OAT;MTX2;NDUFA5;MRPL34;ATP5F1A;FH;NDUFA3;NDUFB8;VDAC3;NDUFB4;ATP5F1D;ATP5MC3;MPC1;NDUFC1;ATP5F1B;NDUFAB1;ATP5PB;COX7A2L;ECHS1;COX6A1;NDUFB6;TIMM50
173,prerank,KEGG_2021_Human__Neurotrophin signaling pathway,0.3625312348872616,0.9177577206063159,0.6160815402038505,0.9288451050857885,1.0,19/55,28.36%,MAPK13;ARHGDIA;BAX;NFKBIB;RELA;RPS6KA1;RIPK2;RAP1B;RAPGEF1;NFKBIA;RHOA;MAPKAPK2;CDC42;PRKCD;CRK;NFKBIE;RAF1;NRAS;PRDM4
174,prerank,KEGG_2021_Human__Viral myocarditis,0.4187933740862315,0.9166569111188658,0.5838926174496645,0.9235669785770847,1.0,6/19,18.09%,CD80;ACTG1;CASP3;ICAM1;BID;CYCS
175,prerank,KEGG_2021_Human__Non-alcoholic fatty liver disease,0.3395351960582437,0.9165576947692764,0.6543730242360379,0.9160185543041067,1.0,21/93,21.86%,PRKAB1;UQCRHL;FAS;MAPK13;DDIT3;TNFRSF1A;CASP3;BAX;ADIPOR2;RELA;BID;NDUFA7;SOCS3;NDUFS4;TRAF2;CYCS;COX8A;CDC42;NDUFS6;MLX;NDUFB9
176,prerank,MSigDB_Hallmark_2020__KRAS Signaling Up,0.3526132986854053,0.9154097097890793,0.6427783902976847,0.9109550536266133,1.0,23/62,24.94%,PSMB8;INHBA;CSF2RA;PLAUR;LAT2;SPP1;CXCL10;BIRC3;HBEGF;RETN;ZNF277;AKAP12;CTSS;ARG1;C3AR1;FCER1G;GNG11;TRIB1;MMP9;TNFAIP3;ADAM8;IL10RA;PTGS2
177,prerank,KEGG_2021_Human__Vasopressin-regulated water reabsorption,-0.32066717278697277,-0.9142075125496304,0.6035242290748899,0.8610941878883881,1.0,2/21,2.87%,PRKACB;GNAS
178,prerank,KEGG_2021_Human__Thyroid cancer,0.4001592511076696,0.9141783447135474,0.61489898989899,0.9059556414235729,1.0,4/24,12.12%,CDKN1A;BAK1;BAX;TPM3
179,prerank,KEGG_2021_Human__Diabetic cardiomyopathy,-0.23766516784383146,-0.9138718328139106,0.6842105263157895,0.8475374817831546,1.0,30/105,18.26%,SLC25A4;PDHA1;COX7B;PIK3CD;SLC25A5;UQCRB;NDUFB5;PLCB2;NDUFS5;UQCR10;NDUFA5;AKT1;GSR;ATP5F1A;ATP2A3;NDUFA3;NDUFB8;VDAC3;NDUFB4;ATP5F1D;ATP5MC3;MPC1;NDUFV3;NDUFC1;ATP5F1B;NDUFAB1;ATP5PB;COX7A2L;COX6A1;NDUFB6
180,prerank,KEGG_2021_Human__Adrenergic signaling in cardiomyocytes,-0.28134003898662646,-0.9130985773096656,0.6466165413533834,0.8357283078131134,1.0,9/42,11.35%,PRKACB;GNAS;PLCB2;CALM3;ADCY7;CALM2;ADRB2;AKT1;ATP2A3
181,prerank,KEGG_2021_Human__Glucagon signaling pathway,0.38217546361094207,0.9130368602718655,0.623121387283237,0.9009020714564565,1.0,8/34,9.76%,PRKAB1;LDHA;PPP4C;PKM;CPT1A;PFKL;LDHC;SLC2A1
182,prerank,KEGG_2021_Human__Gastric cancer,-0.2775494556536497,-0.9110158280011433,0.6766917293233082,0.8278205796597733,1.0,8/42,11.66%,JUP;TCF7;SMAD4;PIK3CD;CDKN1B;AKT1;RPS6KB1;APC
183,prerank,MSigDB_Hallmark_2020__Bile Acid Metabolism,0.3996015081407819,0.9082927035455641,0.6222222222222222,0.903954048266169,1.0,7/27,17.51%,GCLM;CH25H;ABCA1;SCP2;OPTN;PEX16;ACSL5
184,prerank,KEGG_2021_Human__cAMP signaling pathway,-0.2636590220749332,-0.9071022373675235,0.6779661016949152,0.8270451004977393,1.0,11/50,11.35%,PRKACB;GNAS;PIK3CD;CALM3;ADCY7;CALM2;ADRB2;AKT1;RRAS;FOS;ATP2A3
185,prerank,KEGG_2021_Human__Retrograde endocannabinoid signaling,-0.25913512790192067,-0.9036004129098185,0.6694214876033058,0.8233402509020884,1.0,18/53,20.26%,PRKACB;NDUFB5;PLCB2;NDUFS5;ADCY7;NDUFA5;NDUFA3;NDUFB8;NDUFB4;NDUFV3;GNG12;NDUFC1;NDUFAB1;MAPK1;NDUFB6;NDUFB10;NDUFA11;NDUFA4
186,prerank,KEGG_2021_Human__Regulation of actin cytoskeleton,-0.24847208075395869,-0.902528287452487,0.7777777777777778,0.8137882803297998,1.0,8/77,5.02%,FN1;ITGA4;ITGAL;ARHGEF6;ITGB7;WASF2;PIK3CD;ITGB1
187,prerank,KEGG_2021_Human__Purine metabolism,0.3783826616075575,0.9009036818300081,0.6439854191980559,0.9129513109053485,1.0,5/33,6.06%,PKM;NUDT9;NT5C3A;NT5E;IMPDH1
188,prerank,KEGG_2021_Human__Cellular senescence,-0.24856577917751438,-0.8961570340490339,0.7866666666666666,0.8168886472773399,1.0,14/68,13.01%,SLC25A4;ZFP36L1;FOXO1;PPP3CB;PIK3CD;RBL2;SLC25A5;CALM3;CALM2;HIPK1;AKT1;RRAS;HIPK3;VDAC3
189,prerank,KEGG_2021_Human__Sphingolipid signaling pathway,0.34680717817985696,0.8860953019748263,0.6708571428571428,0.9372466824213781,1.0,24/54,32.02%,MAPK13;TNFRSF1A;DEGS1;BAX;CTSD;RELA;BID;SMPD1;TRAF2;RHOA;FCER1G;RAC2;GNAI3;PPP2CA;S1PR4;RAF1;NRAS;SGPP1;SMPD2;PPP2CB;PPP2R3C;SPTLC2;TRADD;NFKB1
190,prerank,MSigDB_Hallmark_2020__DNA Repair,0.3344410592221439,0.8821105432633419,0.7206521739130435,0.9384752555812362,1.0,16/71,24.05%,NUDT9;NT5C3A;TAF12;CMPK2;COX17;TSG101;HCLS1;SDCBP;POLD4;ADRM1;POLR3C;TMED2;VPS28;CLP1;POLR1D;PDE4B
191,prerank,"KEGG_2021_Human__Growth hormone synthesis, secretion and action",-0.27082397110797757,-0.8813470208303399,0.6538461538461539,0.8395973873005675,1.0,7/40,11.22%,PRKACB;GNAS;PIK3CD;PLCB2;ADCY7;AKT1;FOS
192,prerank,KEGG_2021_Human__TGF-beta signaling pathway,0.37495968284979386,0.8740589408596646,0.6496894409937888,0.9473679803385783,1.0,2/27,3.89%,INHBA;NODAL
193,prerank,KEGG_2021_Human__Endometrial cancer,0.3685512683619935,0.8723809312081074,0.6747868453105969,0.9433768434148336,1.0,3/30,8.31%,CDKN1A;BAK1;BAX
194,prerank,KEGG_2021_Human__Relaxin signaling pathway,-0.2620898815042415,-0.8717680645311693,0.7364341085271318,0.8491816535696078,1.0,7/45,11.22%,PRKACB;GNAS;PIK3CD;PLCB2;ADCY7;AKT1;FOS
195,prerank,KEGG_2021_Human__Focal adhesion,0.3408030638464847,0.8686292977829442,0.697986577181208,0.9434443209057127,1.0,17/57,20.34%,ACTG1;CCND3;ZYX;SPP1;MYL12A;BIRC3;VAV1;PARVG;VASP;RAP1B;RAPGEF1;MYL12B;RHOA;IBSP;CDC42;THBS1;PPP1CA
196,prerank,KEGG_2021_Human__Rap1 signaling pathway,0.3329901844374921,0.8666928827668685,0.7181719260065288,0.9403233677792849,1.0,27/69,27.88%,CSF1;RALGDS;ACTG1;MAPK13;VAV1;FPR1;DOCK4;VASP;RAP1B;RAPGEF1;RHOA;PFN1;MAP2K3;CDC42;LCP2;THBS1;EVL;RAC2;P2RY1;GNAI3;CRK;RASSF5;ACTB;RAF1;NRAS;FYB1;VAV3
197,prerank,KEGG_2021_Human__Thermogenesis,-0.22448290692427186,-0.861300771749942,0.9024390243902439,0.8615672417376845,1.0,33/115,19.76%,RPS6;PRKACB;GNAS;COX7B;RPS6KA3;ARID1B;UQCRB;NDUFB5;NDUFS5;ADCY7;UQCR10;SMARCC1;NDUFA5;MAP3K5;RPS6KB1;ATP5F1A;NDUFA3;NDUFB8;NDUFB4;ATP5F1D;ATP5MC3;NDUFV3;NDUFC1;ATP5F1B;NDUFAB1;ATP5PB;COX7A2L;COX6A1;NDUFB6;ATF2;KDM3A;NDUFB10;NDUFA11
198,prerank,KEGG_2021_Human__Prostate cancer,0.3532478943038343,0.8605710531811404,0.6972909305064782,0.9447894969825056,1.0,2/37,1.35%,IL1R2;CDKN1A
199,prerank,KEGG_2021_Human__Hepatocellular carcinoma,0.3257941773359349,0.8569946536535139,0.7217391304347827,0.9446770008758738,1.0,9/60,18.30%,CDKN1A;ACTG1;HMOX1;BAK1;BAX;GSTP1;CSNK1A1L;KEAP1;DVL2
200,prerank,KEGG_2021_Human__Pancreatic secretion,-0.31428923470782366,-0.8565299797077589,0.717391304347826,0.8600399446919649,1.0,6/19,11.35%,PLA2G2D;GNAS;PLCB2;ADCY7;CA2;ATP2A3
201,prerank,KEGG_2021_Human__Amyotrophic lateral sclerosis,0.30422400234498714,0.8565167422999097,0.8131313131313131,0.9385849189416005,1.0,49/186,27.00%,SQSTM1;PSMA5;ACTG1;UQCRHL;MAPK13;DDIT3;GABARAP;TUBA4A;TNFRSF1A;PSMD8;CASP3;BAX;PSMA1;ATP5PO;PSMB3;CASP1;BID;NDUFA7;RAB5A;ADRM1;PSMA6;OPTN;DCTN5;RAB8A;ANXA11;NDUFS4;TRAF2;CYCS;DERL1;PFN1;GABARAPL1;MAP2K3;COX8A;PSMA2;NDUFS6;MCU;TUBA1C;NDUFB9;PSMD12;SETX;SDHB;PSMD3;PSMD4;TPR;BECN1;NDUFC2-KCTD14;ACTB;SOD1;EIF2AK3
202,prerank,MSigDB_Hallmark_2020__heme Metabolism,0.31805668586229846,0.8546717950902046,0.7702127659574468,0.9350327755876137,1.0,19/95,16.66%,GCLM;HBQ1;CCND3;TMEM9B;LPIN2;CTSB;SLC66A2;SLC2A1;TNS1;USP15;BNIP3L;SLC6A9;SDCBP;LAMP2;SIDT2;RCL1;LRP10;CTSE;OPTN
203,prerank,KEGG_2021_Human__Serotonergic synapse,-0.2921619280061182,-0.8539016562233176,0.6793478260869565,0.8535419821638903,1.0,3/25,6.45%,PRKACB;GNAS;PLCB2
204,prerank,KEGG_2021_Human__GABAergic synapse,-0.3125905726221439,-0.8413572649542195,0.717948717948718,0.8660727616582891,1.0,3/17,7.56%,PRKACB;GLUL;ADCY7
205,prerank,KEGG_2021_Human__Protein processing in endoplasmic reticulum,0.31494106610877093,0.8400684238016343,0.7739872068230277,0.9552327859581087,1.0,16/92,22.24%,UBXN1;BAG1;EIF2AK2;DDIT3;BAK1;DNAJC3;BAX;SAR1B;RNF185;UBE2J2;SAR1A;TRAF2;DERL1;UBE2G2;FBXO6;UFD1
206,prerank,MSigDB_Hallmark_2020__Adipogenesis,0.30970566973444635,0.8378447934534762,0.7829373650107991,0.9524128634365943,1.0,16/93,14.72%,PLIN2;IFNGR1;TALDO1;ALDOA;GRPEL1;RNF11;POR;PFKL;ATP5PO;GHITM;RETN;ADIPOR2;TST;STOM;ABCA1;SCP2
207,prerank,KEGG_2021_Human__Parkinson disease,0.30158867962955294,0.8342990703309111,0.8287179487179487,0.9515619588740999,1.0,35/148,24.69%,UBE2L6;UBB;UBA7;PSMA5;UQCRHL;DDIT3;TUBA4A;PSMD8;CASP3;BAX;PSMA1;ATP5PO;PSMB3;UBE2L3;VDAC2;NDUFA7;UBE2J2;ADRM1;PSMA6;UBC;NDUFS4;CYCS;UBE2G2;COX8A;PSMA2;NDUFS6;MCU;TUBA1C;TXN2;NDUFB9;PSMD12;SDHB;GNAI3;PSMD3;PSMD4
208,prerank,KEGG_2021_Human__Cell adhesion molecules,0.3662302612190868,0.8307146958063937,0.7218045112781954,0.9510041652505867,1.0,7/23,13.64%,CD80;CD274;ICAM1;SELPLG;CLDN1;SDC4;CLDN5
209,prerank,KEGG_2021_Human__Platelet activation,0.3310440588779031,0.8302864792550708,0.7517006802721088,0.9448564616766867,1.0,18/45,24.38%,ACTG1;MAPK13;MYL12A;VAMP8;SYK;VASP;PIK3R5;BTK;RAP1B;MYL12B;RHOA;LCP2;FCER1G;PPP1CA;ORAI1;LYN;P2RY1;GNAI3
210,prerank,KEGG_2021_Human__Non-small cell lung cancer,0.3322571580202892,0.8257028165854435,0.7491082045184304,0.9460829199885735,1.0,3/40,8.31%,CDKN1A;BAK1;BAX
211,prerank,KEGG_2021_Human__Phospholipase D signaling pathway,-0.24186181249284328,-0.8252301123939594,0.8791208791208791,0.8851262923701086,1.0,8/51,10.58%,GNAS;AGPAT3;PIK3CD;CYTH4;PLCB2;ADCY7;AKT1;RRAS
212,prerank,KEGG_2021_Human__Adherens junction,0.3687518793563485,0.8186390465164988,0.7261306532663316,0.9512962826874806,1.0,3/22,5.75%,PTPN6;ACTG1;CSNK2B
213,prerank,KEGG_2021_Human__Insulin resistance,0.33112688660312484,0.8176199654936596,0.7668571428571429,0.9464514134433945,1.0,15/41,24.23%,PRKAB1;TNFRSF1A;CPT1A;SLC2A1;TRIB3;RELA;RPS6KA1;SOCS3;NFKBIA;PPP1CA;PPP1R3B;MLX;OGA;PRKCD;NR1H2
214,prerank,KEGG_2021_Human__Oxidative phosphorylation,0.3091202011719768,0.8175909147046493,0.7837259100642399,0.9398660510549258,1.0,18/82,23.67%,ATP6V1F;UQCRHL;ATP6V1G1;TCIRG1;COX17;ATP6V1B2;ATP5PO;ATP6V0E1;NDUFA7;ATP6V0B;ATP6V1C1;NDUFS4;COX8A;NDUFS6;NDUFB9;ATP6V0D1;ATP6V1A;SDHB
215,prerank,KEGG_2021_Human__Notch signaling pathway,0.3556787296977262,0.8154571634187633,0.7452471482889734,0.9368921559716415,1.0,6/23,20.80%,DTX3L;APH1B;DVL2;NUMBL;SNW1;TLE4
216,prerank,KEGG_2021_Human__mRNA surveillance pathway,-0.24096118349494539,-0.8139498180046972,0.8545454545454545,0.8941381480226537,1.0,7/52,12.80%,PNN;PAPOLA;GSPT1;PABPC1;ACIN1;UPF3B;NCBP2
217,prerank,KEGG_2021_Human__MAPK signaling pathway,0.30238217536343226,0.813901793137969,0.8290155440414507,0.9329885475368115,1.0,21/104,19.74%,CSF1;CD14;FAS;MAPK13;DDIT3;MKNK1;TNFRSF1A;MAX;CASP3;DUSP16;RELA;RPS6KA1;MYD88;RAP1B;TRAF2;RELB;MAPKAPK2;MAP2K3;MAPKAPK3;ARRB2;CDC42
218,prerank,KEGG_2021_Human__Cardiac muscle contraction,0.3602264017243693,0.8128287736157666,0.72,0.9282339076581344,1.0,5/21,19.63%,UQCRHL;TPM4;TPM3;SLC9A1;COX8A
219,prerank,KEGG_2021_Human__PI3K-Akt signaling pathway,0.299442035772125,0.8092042056734734,0.8294979079497908,0.9277237162816409,1.0,21/95,20.36%,CSF1;CDKN1A;CCND3;IFNAR2;SPP1;IL4R;GNB2;TLR2;RHEB;CSF3R;RELA;SYK;TLR4;PIK3R5;MCL1;GNB1;YWHAH;IBSP;OSM;THBS1;GNG11
220,prerank,MSigDB_Hallmark_2020__TGF-beta Signaling,0.33231830529498935,0.7940438379880751,0.758830694275274,0.9440722694153889,1.0,8/32,20.34%,CDK9;SKIL;RHOA;TGIF1;IFNGR2;SKI;THBS1;PPP1CA
221,prerank,MSigDB_Hallmark_2020__Estrogen Response Early,0.30742533569232233,0.7724781469395418,0.838452787258248,0.9685336040183053,1.0,8/50,11.93%,P2RY2;BAG1;CISH;CHPT1;ITPK1;MINDY1;SLC2A1;SLC9A3R1
222,prerank,MSigDB_Hallmark_2020__Mitotic Spindle,-0.2059903604439973,-0.7693013153062374,0.9705882352941176,0.9496705185751122,1.0,21/74,19.28%,WASF2;SPTAN1;SMC3;RALBP1;NUMA1;PREX1;SMC4;FLNA;PCM1;APC;EPB41L2;MID1IP1;ARAP3;SEPTIN9;CCDC88A;PCNT;TLK1;UXT;SMC1A;ARHGAP5;DYNC1H1
223,prerank,KEGG_2021_Human__Yersinia infection,0.2917371033964424,0.7674332969087343,0.8611410118406889,0.968777131430649,1.0,28/73,28.61%,ACTG1;RHOG;MAPK13;ARPC3;VAV1;CCL2;ARPC1B;CASP1;RELA;RPS6KA1;TLR4;MYD88;NFKBIA;TRAF2;RHOA;ARPC1A;MAP2K3;CDC42;LCP2;ARPC5;RAC2;NLRC4;CRK;ACTB;FYB1;VAV3;PKN1;TBK1
224,prerank,KEGG_2021_Human__Hippo signaling pathway,0.3136340786108961,0.767086328923724,0.8254716981132075,0.9628641270521555,1.0,4/38,7.77%,ACTG1;CCND3;TPTEP2-CSNK1E;BIRC3
225,prerank,KEGG_2021_Human__Chronic myeloid leukemia,0.3006044480228226,0.7568201036090939,0.8421658986175116,0.9702794467991465,1.0,4/44,12.51%,CDKN1A;BAK1;BAX;RELA
226,prerank,KEGG_2021_Human__Prion disease,0.2728191225565142,0.7556624588141839,0.92,0.9654107452833888,1.0,36/153,25.07%,PSMA5;UQCRHL;NCF2;MAPK13;DDIT3;C1QB;CSNK2B;TUBA4A;C1QA;NCF4;PSMD8;CASP3;BAX;PSMA1;ATP5PO;PSMB3;VDAC2;NDUFA7;ADRM1;PSMA6;NDUFS4;CYCS;CYBA;COX8A;PSMA2;NDUFS6;MCU;TUBA1C;NDUFB9;PSMD12;RAC2;PRKCD;SDHB;PSMD3;PSMD4;CCL5
227,prerank,KEGG_2021_Human__Alzheimer disease,0.26625445400381603,0.7483216679104159,0.9351570415400202,0.9682407803067683,1.0,35/186,21.86%,CSF1;PSMA5;UQCRHL;FAS;EIF2AK2;DDIT3;CSNK2B;TUBA4A;TNFRSF1A;TPTEP2-CSNK1E;PSMD8;CASP3;PSMA1;ATP5PO;PSMB3;APH1B;RELA;VDAC2;MME;BID;NDUFA7;CSNK1A1L;ADRM1;PSMA6;NDUFS4;TRAF2;CYCS;DVL2;COX8A;PSMA2;NDUFS6;MCU;RTN4;TUBA1C;NDUFB9
228,prerank,KEGG_2021_Human__Cholesterol metabolism,0.3397427565169276,0.7480999913876684,0.7957839262187089,0.9622236426221626,1.0,7/18,22.19%,TSPO;VDAC2;ABCA1;NCEH1;MYLIP;LRPAP1;APOA2
229,prerank,KEGG_2021_Human__Peroxisome,-0.2455683704500689,-0.748037048709725,0.8994708994708994,0.9619473890851983,1.0,3/31,4.56%,IDH2;CAT;GSTK1
230,prerank,KEGG_2021_Human__AMPK signaling pathway,0.30361699934038344,0.7480123325096655,0.8481735159817352,0.9561873365681764,1.0,7/44,17.03%,PRKAB1;CPT1A;PFKL;RHEB;ADIPOR2;RAB14;RAB8A
231,prerank,KEGG_2021_Human__MicroRNAs in cancer,0.28987275407392227,0.7475358857942294,0.8661417322834646,0.9506862678123377,1.0,18/56,27.67%,CDKN1A;HMOX1;BAK1;SOCS1;CASP3;UBE2I;MCL1;RHOA;THBS1;DNMT3A;MMP9;CD44;CRK;PTGS2;RASSF1;EZR;RAF1;NRAS
232,prerank,KEGG_2021_Human__Long-term depression,-0.2693988228045428,-0.7462154587449666,0.8837209302325582,0.9514289256710682,1.0,2/19,6.45%,GNAS;PLCB2
233,prerank,"KEGG_2021_Human__Parathyroid hormone synthesis, secretion and action",-0.23599138777357795,-0.7429765454317535,0.9403973509933775,0.9422238538846313,1.0,5/38,7.56%,PRKACB;GNAS;NR4A2;PLCB2;ADCY7
234,prerank,KEGG_2021_Human__Axon guidance,0.30466191983728613,0.7423422153254817,0.8535178777393311,0.9508052045773036,1.0,14/39,27.67%,CFL1;MYL12A;LIMK2;SEMA4D;MYL12B;RHOA;CDC42;SEMA4A;FES;SEMA7A;RAC2;GNAI3;RAF1;NRAS
235,prerank,KEGG_2021_Human__Ras signaling pathway,0.2832574716442769,0.7330588310805926,0.8961748633879781,0.956219280885465,1.0,15/70,21.32%,CSF1;RALGDS;PLA2G5;ETS2;GNB2;RELA;RAB5A;RAP1B;GNB1;BRAP;RHOA;RAB5C;CDC42;GNG11;RGL2
236,prerank,KEGG_2021_Human__Th1 and Th2 cell differentiation,0.3069774064730597,0.7314463901289727,0.8453105968331304,0.9519331712415925,1.0,8/31,18.16%,MAPK13;IFNGR1;IL4R;STAT1;NFKBIB;RELA;NFKBIA;IFNGR2
237,prerank,KEGG_2021_Human__Primary immunodeficiency,0.34011468983016535,0.7263522184597172,0.8319783197831978,0.9520274122943202,1.0,2/16,2.52%,TAP1;TAP2
238,prerank,KEGG_2021_Human__Signaling pathways regulating pluripotency of stem cells,0.293096255499579,0.7195674094505338,0.8596287703016241,0.9537410706470878,1.0,3/39,4.48%,INHBA;NODAL;MAPK13
239,prerank,KEGG_2021_Human__Acute myeloid leukemia,0.2894227443797242,0.7144880014584382,0.8656542056074766,0.9533427831861022,1.0,5/38,12.51%,CD14;PML;SPI1;BCL2A1;RELA
240,prerank,KEGG_2021_Human__ErbB signaling pathway,0.30477870176458466,0.7142295369557194,0.8629629629629629,0.9478479522570176,1.0,2/27,9.35%,CDKN1A;HBEGF
241,prerank,MSigDB_Hallmark_2020__Spermatogenesis,0.32736052486972517,0.7138515310153872,0.8604060913705583,0.9425155756804547,1.0,6/20,20.80%,TALDO1;LDHC;PGS1;LPIN1;AGFG1;TLE4
242,prerank,KEGG_2021_Human__Glycerophospholipid metabolism,0.2892225622484135,0.7078365189189091,0.8747044917257684,0.9429590567322919,1.0,3/37,5.23%,PLA2G5;LPIN2;CHPT1
243,prerank,KEGG_2021_Human__Choline metabolism in cancer,0.2878731555737718,0.7047385141819498,0.9052631578947369,0.9403856892649893,1.0,3/36,9.79%,RALGDS;CHPT1;RHEB
244,prerank,KEGG_2021_Human__Ribosome biogenesis in eukaryotes,-0.21649318280881424,-0.668932474772679,0.9573170731707317,0.9856543142762224,1.0,10/29,20.70%,NOP58;TCOF1;NOP56;BMS1;LSG1;XPO1;REXO2;CSNK2A1;EMG1;RBM28
245,prerank,MSigDB_Hallmark_2020__Protein Secretion,0.26110992261951904,0.656059059164983,0.9340159271899886,0.9760162113381983,1.0,11/48,20.01%,CLTA;CD63;TSG101;PPT1;LAMP2;ABCA1;RAB5A;RAB14;TPD52;TMED2;CLN5
246,prerank,KEGG_2021_Human__Oxytocin signaling pathway,0.26284529220588065,0.655051201243782,0.953125,0.9709896210371648,1.0,3/47,3.16%,CDKN1A;PRKAB1;ACTG1
247,prerank,KEGG_2021_Human__Huntington disease,0.2261439903232945,0.6274518668294305,0.9897119341563786,0.9829491964027931,1.0,23/158,20.03%,PSMA5;CLTA;TBPL1;UQCRHL;TUBA4A;SOD2;PSMD8;CASP3;BAX;PSMA1;ATP5PO;PSMB3;VDAC2;NDUFA7;ADRM1;PSMA6;DCTN5;NDUFS4;TRAF2;CYCS;COX8A;PSMA2;NDUFS6
248,prerank,KEGG_2021_Human__GnRH secretion,-0.2266171776579909,-0.6274491426141248,0.9563318777292577,0.9896676656080869,1.0,3/18,10.35%,PIK3CD;PLCB2;AKT1
249,prerank,KEGG_2021_Human__Spinocerebellar ataxia,0.2371540512369194,0.6195298386407875,0.9747530186608123,0.9816079692049612,1.0,16/68,25.61%,PSMA5;TBPL1;PSMD8;PSMA1;PSMB3;VDAC2;ADRM1;PSMA6;TRAF2;CYCS;PSMA2;MCU;PSMD12;PSMD3;PSMD4;BECN1
250,prerank,KEGG_2021_Human__VEGF signaling pathway,0.2642052091802649,0.6098223100971538,0.9558282208588957,0.9804018719640826,1.0,8/25,27.67%,MAPK13;MAPKAPK2;MAPKAPK3;CDC42;RAC2;PTGS2;RAF1;NRAS
251,prerank,MSigDB_Hallmark_2020__Androgen Response,0.23953344587807163,0.5909615135068679,0.9721577726218097,0.9823499248166125,1.0,12/42,25.75%,CCND3;MYL12A;B2M;UBE2I;AKAP12;TPD52;ADRM1;HPGD;ARID5B;GNAI3;TNFAIP8;PIAS1
252,prerank,KEGG_2021_Human__Various types of N-glycan biosynthesis,0.2528815927248994,0.53084066509282,0.9692513368983957,0.9918196691510635,1.0,5/15,30.36%,ALG14;MGAT4A;MAN1B1;MGAT4B;ALG12
253,prerank,KEGG_2021_Human__Protein export,-0.17982707969987183,-0.4820691759158885,0.9956896551724138,0.9982921083627797,1.0,6/18,24.86%,SPCS3;SPCS1;SEC61B;SRP72;HSPA5;SRP68
